WuXi has disputed an early WBJ report saying construction at the Worcester site has stopped, although the company declined to ...
3d
Pharmaceutical Technology on MSNWuXi XDC and AbTis collaborate on antibody-drug conjugatesThe partnership combines AbTis' AbClick site-selective conjugation platform with WuXi XDC's all-in-one development and ...
If you are planning to travel to Wuxi or any other city in China, this airport locator will be a very useful tool. This page gives complete information about the Wuxi Airport along with the airport ...
Four years later, and my Chinese has improved (a bit) and I have come to love the ebb and flow of life in the beautiful city ...
WuXi XDC Cayman Inc. ("WuXi XDC", or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, ...
Hong Kong IPO: WuXi Biologics unit eyes up to US$520 million in biotech push WuXi XDC, a 60 per cent-owned unit of WuXi Biologics, could raise as much as US$520 million, including excess share ...
Recognized as a leader in Green CRDMO, driving innovation for a healthier future SHANGHAI, Feb. 18, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research ...
Chinese electric-car maker Li Auto and pharmaceutical company WuXi Apptec will join the Hang Seng Index as new constituents next month, according to the latest quarterly review by Hong Kong’s ...
About WuXi XDC WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK) is a leading global CRDMO focused on antibody drug conjugates (ADC) and the broader bioconjugate market.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results